| CASE REPORT |
|
| Year : 2021 | Volume
: 5
| Issue : 4 | Page : 157-160 |
|
|
A case report: Steroid-induced mania in the context of COVID-19: The compounding impact of treatment on mental health
John Michael Perez1, Spencer Murdock1, Sarah Singh2, Wanhong Zheng1
1 Department of Behavioral Medicine and Psychiatry, West Virginia University School of Medicine, Morgantown, West Virginia, USA
2 Department of Radiation Oncology, West Virginia University School of Medicine, Morgantown, West Virginia, USA
Correspondence Address:
Dr. Wanhong Zheng
Department of Behavioral Medicine and Psychiatry, West Virginia University School of Medicine, Morgantown, West Virginia
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/hm.hm_17_21
|
|
|
The coronavirus disease 19 (COVID-19) pandemic has negatively affected people's day-to-day lives, especially those with mental illness. We present a case of a manic episode with psychotic features induced by dexamethasone administered as part of COVID-19 treatment. The patient had underlying depression, anxiety, and posttraumatic stress disorder, but was stable before contracting COVID-19. The implications of quarantine and social stress on mood stability are also discussed. We call for better patient education on the risks of steroid-induced mania and psychosis as well as increased attention to mental illness screening and treatment during this unprecedented pandemic time.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
